RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
  Prion Diseases
  Small Pox
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Influenza Channel

subscribe to Influenza newsletter
Latest Research : Infectious Diseases : Influenza

   EMAIL   |   PRINT
Researchers Reconstruct 1918 Pandemic Influenza Virus

Oct 6, 2005 - 9:26:00 PM
“By identifying the characteristics that made the 1918 influenza virus so harmful, we have information that will help us develop new vaccines and treatments. Influenza viruses are constantly evolving, and that means our science needs to evolve if we want to protect as many people as possible from pandemic influenza.”

[RxPG] Influenza pandemics occur when a new strain emerges to which people have little or no immunity. Most experts believe another pandemic will occur, but it is impossible to predict which strain will emerge as the next pandemic strain, when it will occur or how severe it will be.

Scientists at the Centers for Disease Control and Prevention have successfully reconstructed the influenza virus strain responsible for the 1918 pandemic, a project that greatly advances preparedness efforts for the next pandemic.

“This groundbreaking research helps unlock the mystery of the 1918 flu pandemic and is critically important in our efforts to prepare for pandemic influenza,” said CDC Director Dr. Julie Gerberding. “We need to know much more about pandemic influenza viruses. Research such as this helps us understand what makes some influenza viruses more harmful than others. It also provides us information that may help us identify, early on, influenza viruses that could cause a pandemic.”

The work, done in collaboration with Mount Sinai School of Medicine, the Armed Forces Institute of Pathology and Southeast Poultry Research Laboratory, determined the set of genes in the 1918 virus that made it so harmful. This week’s issue of Nature also includes a related article entitled “Characterization of the 1918 influenza virus polymerase genes” which describes the final three gene sequences of the 1918 influenza virus. The 1918 pandemic killed an estimated 20-50 million people worldwide, including 675,000 in the United States. The pandemic’s most striking feature was its unusually high death rate among otherwise healthy people aged 15-34. During normal seasonal flu outbreaks, severe complications and death are most common among the elderly and young children.

The Spanish Flu Pandemic, also known as the Great Influenza Pandemic, the 1918 Flu Epidemic, and La Grippe, was an unusually severe and deadly strain of influenza, a viral infectious disease, that killed some 25 million to 50 million people worldwide in 1918 and 1919. It is thought to have been one of the most deadly pandemics so far in human history.

“Influenza viruses are constantly evolving, and that means our science needs to evolve if we want to protect as many people as possible from pandemic influenza.”

In reconstructing the 1918 influenza virus, researchers learned which genes were responsible for making the virus so harmful.

In September 2000, Noymer and Garenne published a study that poses an ætiological theory explaining the unusual W-shaped mortality age profile of the virus. This profile is characterized by a mode in the 25–34-year age group. Usually, influenza has a U-shaped profile, being most deadly to the young and the old. Additionally, after the pandemic the difference in life expectancy between men and women decreased (women had a historically longer life expectancy). Noymer and Garenne have causally linked these two anomalies with the predominantly-male mortality of tuberculosis.

In October 2002, the Armed Forces Institute of Pathology teamed up with a microbiologist from the Mount Sinai School of Medicine in New York. Together, they started to reconstruct the Spanish Flu. In an experiment, published in October 2002, they were successful in creating a virus with two 1918 genes. This virus was much more deadly to mice than other constructs containing genes from contemporary influenza virus. The experiments were conducted under high biosafety conditions at a laboratory of the US Department of Agriculture in Athens, Georgia.

In the February 6, 2004, edition of Science magazine it was reported that two teams of researchers, one led by Sir John Skehel, director of the National Institute for Medical Research in London and another by Professor Ian Wilson of the Scripps Research Institute in San Diego had managed to synthesize the hemagglutinin protein responsible for the 1918 outbreak of Spanish Flu by piecing together DNA procured from a lung sample taken from the body of an Inuit woman buried in the Alaskan tundra and a number of preserved samples taken from American soldiers of the First World War. The two teams had analyzed the structure of the gene and discovered how subtle alterations to the shape of a protein molecule had allowed it to move from birds to humans with such devastating effects.

Publication: Published in the Oct. 7 issue of Science
On the web: Spanish flu in Wikipedia 

Advertise in this space for $10 per month. Contact us today.

Related Influenza News
Genetic studies to explain the difference in susceptibility to the flu
Influenza predisposes to secondary bacterial infections
Closing schools for short periods does not decrease infection rates
Clinical trials of 2009 H1N1 influenza vaccines
Analysis of a critical protein produced by the 2009 H1N1 influenza A virus
Flu shot rates lag for adolescents at risk
Immune to avian flu?
Novel H3N1 Swine Influenza Virus Identified in Pigs in Korea
Are influenza vaccines worth the effort?
Oseltamivir significantly reduces the risk of death from influenza

Subscribe to Influenza Newsletter

Enter your email address:

 Additional information about the news article
CDC employed stringent biosafety and biosecurity precautions during research on the 1918 influenza virus. The work was done in a high containment Biosafety Level 3 lab with enhancements that include special provisions to protect both laboratory workers and the public from exposure to the virus. Currently available antiviral drugs have been shown to be effective against influenza viruses similar to the 1918 influenza virus.

All laboratory work was conducted at CDC. The work was supported in part with funding from the U.S. Department of Agriculture and the National Institutes of Health.

To evaluate the benefits of publishing the information contained in these manuscripts and any potential threat from its possible deliberate misuse, both manuscripts were reviewed by the National Science Advisory Board on Biosecurity (NSABB). The NSABB advises the federal government on strategies for the conduct and communication of research that might yield information or technologies that could be misused to threaten public health or national security. The Board was unanimous in its determination that it was critically important to make these findings available to the scientific community at large to not only validate their significance, but also permit further research on the development of diagnostic tests, treatments, and preventative measures.

Additional References: 1. http://en.wikipedia.org/wiki/Spanish_Flu From Wikipedia, the free encyclopedia under the terms of the GNU Free Documentation License
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)